Merck KGaA
MKGAF
$127.21
-$5.94-4.46%
OTC PK
| 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | |
|---|---|---|---|---|---|
| Revenue | 2.26% | 1.31% | 0.79% | -0.56% | -2.19% |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 2.26% | 1.31% | 0.79% | -0.56% | -2.19% |
| Cost of Revenue | 1.63% | -1.51% | 0.85% | 2.88% | 5.29% |
| Gross Profit | 2.71% | 3.34% | 0.76% | -2.83% | -6.91% |
| SG&A Expenses | 4.10% | 2.47% | 1.88% | -1.32% | -1.79% |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -76.53% | -13.94% | -45.41% | 189.48% | 38.16% |
| Total Operating Expenses | -2.19% | -1.43% | -1.26% | 3.82% | 3.42% |
| Operating Income | 24.94% | 14.43% | 10.37% | -17.64% | -23.39% |
| Income Before Tax | 12.04% | 5.46% | 1.57% | -7.16% | -14.17% |
| Income Tax Expenses | 21.65% | 19.20% | 15.54% | -13.17% | -22.46% |
| Earnings from Continuing Operations | 9.73% | 2.25% | -1.63% | -5.55% | -11.91% |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -71.70% | 42.41% | 17.79% | 41.20% | 51.52% |
| Net Income | 9.57% | 2.45% | -1.57% | -5.38% | -11.72% |
| EBIT | 24.94% | 14.43% | 10.37% | -17.64% | -23.39% |
| EBITDA | 17.36% | 10.30% | 7.57% | -9.94% | -14.59% |
| EPS Basic | 9.41% | 2.41% | -1.47% | -5.28% | -11.57% |
| Normalized Basic EPS | 20.28% | 14.39% | 10.45% | -11.66% | -17.71% |
| EPS Diluted | 9.50% | 2.49% | -1.39% | -5.36% | -11.65% |
| Normalized Diluted EPS | 20.28% | 14.39% | 10.45% | -11.66% | -17.71% |
| Average Basic Shares Outstanding | 0.14% | 0.02% | -0.11% | -0.11% | -0.17% |
| Average Diluted Shares Outstanding | 0.14% | 0.02% | -0.11% | -0.11% | -0.17% |
| Dividend Per Share | -0.99% | -0.99% | -0.99% | 5.37% | 5.37% |
| Payout Ratio | -0.03% | -0.11% | -0.10% | -0.06% | 0.00% |